SCHEMBL9876918

SCHEMBL9876918

O=C1CCC(CCc2ccccc2)N1O

nearest known ligand 0.51

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SLC18A2 Q05940 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9877820 0.91 NAAA (0.43) SLC18A2
SCHEMBL9877016 0.91 SLC18A3 (0.41)
SCHEMBL9879730 0.87 FFAR1 (0.49)
SCHEMBL9877336 0.83 HCRTR1 (0.45)
SCHEMBL9707392 0.81 SLC18A2 (0.38) SLC18A2
SCHEMBL11031319 0.77 SLC18A2 (0.42) SLC18A2
SCHEMBL9331285 0.75 MFN2 (0.41)
SCHEMBL9328954 0.73 HSD17B2 (0.40)
SCHEMBL9328964 0.73 HSD17B2 (0.40)
SCHEMBL9328959 0.73 HSD17B2 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5036157-A Hydroxamic acid derivatives, lipoxygenase and cyclooxygenase inhibitors, anticoagulants, antiinflammatory agents BURROUGHS WELLCOME CO. 1991-07-30 US disclosed
US-4977188-A Hydroamic acid derivatives BURROUGHS WELLCOME CO. (US) 1990-12-11 US disclosed
WO-1990001929-A1 NEW MEDICAL USE THE WELLCOME FOUNDATION LIMITED (GB) 1990-03-08 WO disclosed
US-4738986-A CYCLOOXYGENASE, LIDOXYGENASE INHIBITORS BURROUGHS WELLCOME CO. (US) 1988-04-19 US disclosed
EP-0196184-A2 Aryl derivatives THE WELLCOME FOUNDATION LIMITED (GB) 1986-10-01 EP disclosed